June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Europe's STOXX 600 ends lower as rate uncertainty prevails

Published 05/21/2024, 03:21 AM
Updated 05/21/2024, 12:26 PM
© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, May 13, 2024. REUTERS/Staff/File Photo
GASI
-
NVDA
-
AZN
-
STOXX
-

By Sruthi Shankar and Johann M Cherian

(Reuters) -European stocks closed slightly lower on Tuesday, their third out of four sessions in the red, as caution around interest rate reductions dominated, with investors waiting for economic data due later in the week.

The pan-European STOXX 600 index ended 0.2% lower, after hitting a one-week low earlier in the session, with banks and luxury stocks leading sectoral losses, down around 0.9% each.

The lender-heavy Italian share index lagged regional peers, dropping 0.6% to hit a more than one-week low.

The STOXX index has eased from record highs since European Central Bank policymakers cautioned against expecting successive interest rate reductions in June and July.

Traders anticipate cuts worth 66 basis points from the ECB by year-end, according to the LSEG rate probabilities app, with the first seen in June.

Eurozone negotiated wage data for the first quarter along with May manufacturing data expected on Thursday could shed light on the state of the economy and offer clues to the trajectory of interest rates.

"Eurozone productivity is weak, so the bulk of the increase in labour costs over Q1 most likely reflects higher employee compensation. Elevated eurozone wage pressures suggest the easing cycle will be shallow," said Win Thin, global head of markets strategy at Brown Brothers Harriman.

Investors will also focus on minutes from the Fed's last policy meeting and chip giant Nvidia (NASDAQ:NVDA)'s earnings on Wednesday to see if the recent momentum that pushed U.S. and European equities to record highs continues.

On Tuesday, data showed German producer prices fell more than expected in April, mainly due to lower energy prices.

Drugmaker AstraZeneca (NASDAQ:AZN) rose 2.2%, among top gainers on the UK's main FTSE 100 index, after saying it aimed to increase revenue by about 75% to $80 billion by 2030.

The broader healthcare sector outperformed the main STOXX index with a 0.7% climb.

Italy's top insurer, Generali (BIT:GASI), dipped 1.5% after reporting first-quarter results, with some analysts pointing to lower-than-expected profitability in the property and casualty business.

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, May 13, 2024. REUTERS/Staff/File Photo

The energy contractor Saipem rose 4% after securing $3.7 billion in contracts with a subsidiary of French oil major TotalEnergies (EPA:TTEF).

Swiss fastening systems maker SFS Group climbed 8%, after UBS upgraded the stock to "Buy" from "Neutral".

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.